ArticleCancer science2011

HLA-A2-restricted glypican-3 peptide-specific CTL clones induced by peptide vaccine show high avidity and antigen-specific killing activity against tumor cells.

Toshiaki Yoshikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.